866-997-4948(US-Canada Toll Free)

Published on : Mar 16, 2017

ALBANY, NY, March 16, 2017: The Baltic countries seasonal influenza vaccination market is expected to display the ascendancy of Lithuania and Latvia with regard to adult vaccination, accounting for a 95.0% share in 2022. In 2016, both these countries had dominated the market share of children vaccination by a spectacular 70.0%. Besides the aforementioned market figures, a report added by ResearchMoz.us also gives out the statistics of Estonia, which is foreseen to follow second to Lithuania in the race of attaining the highest market share for seasonal influenza vaccination. The report is titled “Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast.”

While all the three Baltic countries are comprehensively explored in the report, each of them is analyzed according to two viewpoints, i.e. the overall seasonal influenza vaccine market and size of seasonal influenza vaccinated population. The review period considered for the seasonal influenza vaccine market in Baltic countries is 2011–2016 and forecast period is 2017–2022. The analysts have explicitly shed light on the forecast of the children and adult seasonal influenza vaccine markets and vaccinated population.

Some of the critical challenges anticipated to raise their heads in the Baltic countries seasonal influenza vaccination market are limited access to vaccines and low reimbursement, insufficiency of healthcare infrastructure, and regulatory issues related to new and unconventional influenza vaccines.

Click to get more details with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=998974

However, the report has also shared some of the prominent growth drivers of the Baltic countries seasonal influenza vaccination market. They include the rise in the share of healthcare expenditure in the Baltic nations, elevating number of aging and child population in the Baltic region, and surge in flu vaccine production planned by manufacturers. Owing to these factors, the seasonal influenza vaccination market in Baltic countries is predicted to see a classic growth in demand.

Children are foretold to bear a substantial burden of seasonal influenza with attacks towering to an alarming 20.0% to 30.0%. In this regard, the need for reliable vaccines for children exposed to the risk of influenza is prognosticated to augment to a significant level. Influenza type B virus strain, influenza type A with H1N1 virus strain, and influenza type A with H3N2 virus strain are the three types of flu shot grouped as a complete set of influenza vaccine.

Major players of the seasonal influenza vaccine market in Baltic countries are prophesied to make the cut with a strong product portfolio being developed on the back of breakthrough pipeline vaccines. Players can also take advantage of the growing support from governments to fight against influenza through immunization and rising awareness propelled by the fear of pandemic influenza.

The 71-page analysis of the seasonal influenza vaccine market in Baltic countries is a precise and to the point account which helps to understand the situation in Lithuania, Estonia, and Latvia and implement effective growth strategies.

To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on sales@researchmoz.us